News | December 12, 2022
Entod Pharmaceuticals to launch GLO division
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)